The reduced LRP1-mediated brain-to-blood clearance of monomeric Aβ, due to the receptor degradation by PCSK9, was demonstrated in an established BBB model and further confirmed in an AD mouse model, in prefrontal cortex and hippocampus areas critically involved in memory processing [89]. This evidence concerns the gene LRP1 and Alzheimer disease.